U.S. Tributyrin Market Size, Share & COVID-19 Impact Analysis, By Type (Purity 45% and Below, Purity 45% - 99%, Purity 99% and Above), and By Application (Food Additive, Feed Additive, and Others), and Country Forecast, 2023-2030

The U.S. tributyrin market size was worth USD 26.9 million in 2022 and is projected to grow at a CAGR of 8.6% during the forecast period.

The U.S. has observed a significant rise in the demand for animal feed due to the strong growth of livestock farming. Animal feed improves immunity and health, accelerates growth and is the most important source of nutrition for animals. Manufacturers are extensively using tributyrin to make this feed. Their use in animal feeds helps reduce the risk of diseases in animals. Therefore, the rising incidence of animal diseases and increasing demand for eggs, meat, and dairy products will positively impact its usage in animal feeds. Also, tributyrin is being widely demanded to reduce strong meat odor from animal-derived products. These factors will drive market share in the future.

The initial phase of the pandemic hampered the U.S. tributyrin market growth due to strict movement regulations and lockdowns. These factors resulted in a complete halt of manufacturing activities and forced some manufacturers to reduce their production. Moreover, movement and trade restrictions disrupted the supply chain networks in the market. On the other hand, the increasing number of patients during the outbreak and growing public awareness of sanitation, hygiene, and healthy eating habits resulted in a higher demand for tributyrin products from the pharmaceutical and food industries. Additionally, the growing production of livestock across the globe during the pandemic due to the rising demand for animal feeds positively impacted the market.

LATEST TRENDS

Growing Product Demand from Pharmaceutical Industry to Propel Market Growth

Tributyrin is being increasingly demanded by the pharmaceutical industry for cancer treatment, especially colon cancer. The surging incidence of cancer will propel the product use in the pharmaceutical industry as it can potentially prevent colon cancer. In the U.S., colon cancer is a significant reason for cancer-related deaths in both women and men. As per estimates by the American Cancer Society, in 2023, the U.S. recorded 106,970 new cases of colon cancer, which caused about 52,550 deaths.

Moreover, pharmaceutical product manufacturers are focusing on new developments, such as increasing research & development activities and collaborating with private & public companies. These research & development activities are conducted in medical technologies and novel drugs that increase the demand for anti-cancer drugs. Such developments are favoring the growth of the market.

DRIVING FACTORS

Increasing Demand for Animal Feed to Drive Market Growth

Rising awareness about the importance of adequate nutrition intake and consumption of animal feed products to improve animal health has encouraged farmers to introduce animal feeds into the diet of their livestock.

According to the Food and Agriculture Organization (FAO) of the U.S., food demand is expected to grow by 60% by 2050. Between 2010 and 2050, animal protein production is projected to grow by nearly 1.7% per year, with aquaculture production expected to increase by 90%, meat production by nearly 70%, and dairy production by 55%. Thus, it will ultimately increase the demand for tributyrin.

RESTRAINING FACTORS

Volatility in Raw Material Prices to Restrain Market Growth

Esterification of butyric acid and glycerol results in the production of tributyrin. However, fluctuating prices of butyric acid due to supply chain constraints and the monopoly of Chinese manufacturers are restraining market growth.

Moreover, the market is still emerging across the globe. The key players are investing in R&D to produce more efficient products for end-users. Tributyrin is useful in cancer-related drugs. Pharmaceutical companies are adopting tributyrin agents in drug manufacturing. So, high costs associated with research & development programs and new drug development, coupled with the threat of failure and adverse effects, also increase the product cost, thereby hampering market progress.

SEGMENTATION

By Type Analysis

Based on type, the market is segmented into purity 45% and below, purity 45% - 99%, and purity 99% and above. The purity 45% - 99% segment held a larger U.S. tributyrin market share in 2022 owing to the high demand for livestock in the country.

• As per the U.S. Department of Agriculture, the total sales of the poultry sector in the country in 2022 were USD 76.9 billion, an increase of 67% from 2021. Egg sales increased 122%, broiler sales increased 60%, and turkey sales increased 21%.

By Application Analysis

Based on application, the market is segmented into food additive, feed additive, and others. The feed additive segment is projected to remain the dominant segment during the forecast period. Feed additive is used mainly in livestock diets.

• As per the U.S. National Chicken Council (NCC), the country's per capita consumption of poultry and livestock has gradually increased in the last few years. Total red meat & poultry consumption stood at 224.1, 224.8, and 226.8 pounds in 2020, 2021, and 2022, respectively.

KEY INDUSTRY PLAYERS

In terms of the competitive landscape, the market depicts the presence of established and emerging tributyrin manufacturing companies. Key players include Perstorp, Thermo Fisher Scientific, MP Biomedicals, and Sigma-Aldrich Co. LLC, among others. These players are competing on the price and application areas of the product. They are emphasizing product innovation, social marketing, acquisition, and collaboration strategies.

LIST OF KEY COMPANIES PROFILED:

• Perstorp (Sweden)


• Thermo Fisher Scientific (U.S.)


• MP Biomedicals (U.S.)


• Sigma-Aldrich Co. LLC (U.S.)


• Spectrum Chemical Mfg. Corp. (U.S.)


• Vetagro S.p.A. (Italy)


• Proviron (U.S.)

KEY INDUSTRY DEVELOPMENTS: 

• October 2022 – Petronas Chemicals Group Berhad (PCG) completed the acquisition of Perstorp for USD 1.54 billion, based on an enterprise value of USD 2.5 billion. With this acquisition, the company expanded its global presence by strengthening its position in Asia Pacific.

REPORT COVERAGE

The market research report thoroughly examines key factors, such as profiles of leading companies, top product applications, and types. It also provides information on market trends and highlights significant industry advancements. The study includes different factors that have contributed to the market's growth in recent years. It covers market analysis and studies the industry's newest dynamics, U.S. tributyrin market opportunities, historical data, and revenue growth estimates at the country level.

Report Scope & Segmentation